Drug profile · INN
relugolix + estradiol + norethisterone acetate
RYEQO
relugolix + estradiol + norethisterone acetate (RYEQO) is an FDA-listed pharmaceutical active ingredient. Associated with Gedeon Richter Australia Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — relugolix + estradiol + norethisterone acetate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
relugolix + estradiol + norethisterone acetate (RYEQO) is an FDA-listed pharmaceutical active ingredient. Associated with Gedeon Richter Australia Pty Ltd.
Key facts
INN relugolix + estradiol + norethisterone acetate
Brand RYEQO
Originator Gedeon Richter Australia Pty Ltd
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is relugolix + estradiol + norethisterone acetate?
relugolix + estradiol + norethisterone acetate (RYEQO) is an FDA-listed pharmaceutical active ingredient. Associated with Gedeon Richter Australia Pty Ltd.
What is the brand name for relugolix + estradiol + norethisterone acetate?
RYEQO is a marketed brand name for relugolix + estradiol + norethisterone acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.